Evidence map›Paper›PMID 30640922›Full record

ArticlePloS one2019

Molecular characterization of influenza A(H1N1)pdm09 in Cameroon during the 2014-2016 influenza seasons.

Chavely Gwladys Monamele, Hermann Landry Munshili Njifon, Marie-Astrid Vernet, Mohamadou Ripa Njankouo, Sebastien Kenmoe, Ali Ahmed Yahaya, Louis Deweerdt, Raphael Nono, Wilfred Mbacham, Damian Nota Anong and 2 more

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed, 1 pooled it
1.8field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 1 synthesis or guideline pooled it, 18 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Review
  5. Article
  6. Iranian journal of microbiology · 2020
    Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 4 institutions in 2 countries.

Chavely Gwladys MonameleNational Influenza Centre, Centre Pasteur of Cameroon, Yaoundé, Cameroon.
Hermann Landry Munshili NjifonCentre Pasteur of Cameroon, Annex of Garoua, Garoua, Cameroon.
Marie-Astrid VernetNational Influenza Centre, Centre Pasteur of Cameroon, Yaoundé, Cameroon.
Mohamadou Ripa NjankouoNational Influenza Centre, Centre Pasteur of Cameroon, Yaoundé, Cameroon.
Sebastien KenmoeNational Influenza Centre, Centre Pasteur of Cameroon, Yaoundé, Cameroon.
Ali Ahmed YahayaWorld Health Organisation, Regional Office for Africa, Brazzaville, Congo.
Louis DeweerdtCentre Pasteur of Cameroon, Annex of Garoua, Garoua, Cameroon.
Raphael NonoCentre Pasteur of Cameroon, Annex of Garoua, Garoua, Cameroon.
Wilfred MbachamUniversity of Yaoundé 1, Yaoundé, Cameroon.
Damian Nota AnongUniversity of Buea, Buea, Cameroon.
Jane Francis AkoachereUniversity of Buea, Buea, Cameroon.
Richard NjouomNational Influenza Centre, Centre Pasteur of Cameroon, Yaoundé, Cameroon.ORCID 0000-0003-3112-6370
Centre Pasteur du Cameroun · CMUniversity of Buea · CMUniversité de Yaoundé I · CMWorld Health Organization Regional Office for Africa · CG

Funding

World Health Organization 001
6 · The paper itself

Abstract

In 2009, Influenza A(H1N1)pdm09 caused the first influenza pandemic of the 21st century with high mortality rates of about 284 500 deaths. This virus, however, continues to circulate as a seasonal influenza virus and to cause illness and deaths worldwide. In this study, we describe the genetic diversity of A(H1N1)pdm09 viruses collected between 2014 and 2016 in Cameroon. Three gene segments (HA, NA and M) of Cameroon strains were studied. The phylogenetic tree of the coding nucleotide sequences was generated by MEGA version 6.0 using a Maximum Likelihood method. The NA and M protein coding sequences were analyzed for the reported genetic markers of resistance against neuraminidase inhibitors and adamantanes, while predicted vaccine efficacy was estimated using the Pepitope method. Overall 39 strains were obtained. Phylogenetic analysis of the HA gene of influenza A(H1N1)pdm09 showed that Cameroon strains belonged to two major clades. The 2014 Cameroon sequences belonged to clade 6C while all sequences collected between 2015 and 2016 belonged to clade 6B. Majority of the samples had some mutations in the NA gene notably: I117M, N248D, and N369K while the amantadine-resistant M mutant, S31N, was found to be absent only in the two sequences collected in 2014. Overall, A/California/07/2009 vaccine strain showed a predicted vaccine efficacy of 24.55% to 35.77% against Cameroon A(H1N1)pdm09 strains circulating between 2014 and 2016. Our findings confirms the fast evolution of A(H1N1)pdm09 since its first introduction and highlights on the importance of influenza vaccine in reducing the burden caused by influenza in the community.

Indexed as

PhylogenyAmantadineAntiviral AgentsCameroonDrug Resistance, ViralHemagglutinin Glycoproteins, Influenza VirusHumansInfluenza A Virus, H1N1 SubtypeInfluenza, HumanInfluenza VaccinesMicrobial Sensitivity TestsMutationMutation RateNeuraminidaseRNA, ViralAmantadineAntiviral AgentsH1N1 virus hemagglutininHemagglutinin Glycoproteins, Influenza VirusInfluenza VaccinesNeuraminidaseRNA, Viral

Identifiers

PMID30640922
PMCPMC6331099
OpenAlexW2909338596

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.